[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Urinary Catheters Market Insights, Competitive Landscape and Market Forecast–2026

January 2022 | 100 pages | ID: UEDF7D3F803DEN
DelveInsight

US$ 4,750.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 7-10 Business Days

Urinary Catheters Market By Product Type (Indwelling/Foley Catheters, Intermittent Catheters, And External Catheters), By Type (Coated And Uncoated), By Design (Single Lumen, Double Lumen, And Triple Lumen), By Usage (Male Urinary Catheters And Female Urinary Catheters), By Application (Benign Prostatic Hyperplasia, Urinary Incontinence, General Surgery, And Others), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), By Geography, is expected to grow at a constant CAGR forecast till 2026 due to the growing prevalence of urological disorders such as urinary incontinence, blockages in urethra, and others among the population and growing burden of geriatric population worldwide

The global Urinary Catheters market was valued at USD 3.10 billion in 2020, growing at a CAGR of 6.63% during the forecast period from 2021 to 2026, to reach USD 4.55 billion by 2026. The increase in demand for urinary catheters is predominantly attributed to the growing cases of urological disorders such as urinary incontinence, Benign Prostatic Hyperplasia, among others, rising old age population across the globe, increase in the number of surgical procedures, and advancement in the materials used to manufacture urinary catheters, among others.

Urinary Catheters Market Dynamics:

The demand for urinary catheters is burgeoning at present due to the rising prevalence of urological disorders such as urinary strictures, urinary incontinence, benign prostatic hyperplasia, and various other indications among the worldwide population. For instance, as per the World Health Organization 2017 data, the prevalence of urinary incontinence ranges from 9.9% to 36.1% population affecting older women as compared to older men. Also, according to the Continence Foundation of Australia 2020 data, incontinence affects one in four adult Australians. Moreover, the data also depicts that approximately 38% of Australian women and around 10% of Australian men were affected with urinary incontinence. Also, the data stated that in the male the urge incontinence is low in younger men and shoots up to 30% for men aged 70-84 and approximately 50% for men above 85 years.

Furthermore, as per Scotland's National Health Information Service 2021 data, an estimated 3 to 6 million people in the United Kingdom have some degree of urinary incontinence.

Thus, rising incontinence disorder could be a potential factor responsible for the global urinary catheters market growth.

Moreover, the rising number of surgeries across the globe is also anticipated to fuel the urinary catheters market. According to the Global Surgery Foundation 2021 report, an estimated 30% of the global burden of disease is caused by conditions that can be treated by surgery.

Henceforth, the above-mentioned factors will contribute to the global urinary catheters market growth during the forecasted period.

However, certain factors such as the risk of developing urinary tract infection and complications associated with catheterization are expected to pose a challenge to the Urinary Catheters market growth.

Urinary Catheters Market Segment Analysis:

Urinary Catheters Market By Product Type (Indwelling/Foley Catheters, Intermittent Catheters and External Catheters), By Type (Coated and Uncoated), By Design (Single Lumen, Double Lumen and Triple Lumen), By Usage (Male Urinary Catheters and Female Urinary Catheters), By Application (Benign Prostatic Hyperplasia, Urinary Incontinence, General Surgery, and Others), By End-User (Hospitals, Ambulatory Surgical Centres, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Urinary Catheters product segment, the intermittent catheter is projected to hold a large market share during the forecasted period. This is owing to the ease of use and affordable price of these catheters. Additionally, intermittent catheters are highly preferred over indwelling catheters because the latter generally leads to urinary tract infections (UTI). The presence of favourable reimbursement policies by the government and public association for intermittent urinary catheters could also contribute to the market growth for urinary catheters. For instance, there are two main ways to get intermittent catheters reimbursed—through Medicare or private insurance in the US. Insurance coverage of catheters and supplies varies with each person’s plan, whether private or government-sponsored.

Also, approval for new intermittent catheter products is anticipated to propel the market for urinary catheters in the forthcoming years. For instance, in the year 2020, B. Braun Medical, Inc. received the US FDA approval for Actreen® Hi-Lite Intermittent Urinary Catheters indicated for intermittent urinary catheterization of paediatric and adult patients with chronic urine retention or voiding dysfunction.

Hence, all the aforementioned factors will lead to the segmental growth of the urinary catheters market in the coming years.

North America is expected to dominate the overall Urinary Catheters Market:

Among all the regions, North America is expected to occupy a major share in the overall urinary catheters market during the forthcoming years. This domination is owing to the increasing occurrence of targeted indications, such as urinary retention, urinary incontinence, bladder obstruction, Benign Prostatic Hyperplasia & bladder cancers, among others. In addition, the presence of well-established healthcare facilities and reimbursement scenarios in the region will also contribute to the urinary catheters market.

Further, in the United States, the growing aging population as compared to the earlier years is also a contributing factor for the urinary catheters market in the region as aged people are more prone to develop various urology-associated disorders. According to the Administration for Community Living (operating division of the US Department of Health and Human Services) 2021 data, there was approximately 54.1 million population above age 65 in the year 2019 which accounted for 16% of the total population and is estimated to increase by 21.6% by the year 2040.

High prostate cancer cases in the region is also projected to increase the demand for urinary catheters as it causes difficult in urination. For instance, as per the American Cancer Society 2021 statistics, about 248,530 new cases of prostate cancer is reported in the same year.

In addition, increase surgical procedures for the treatment of benign prostatic hyperplasia (BPH) along with well-established surgical guidelines for the BPH treatment in the region is also anticipated to augment the market for urinary catheters market in the region. For instance, according to the Urology Care Foundation 2021 data, an estimated 150,000 men undergo transurethral resection of the prostate (TURP) surgery each year, leading to the high demand of urinary catheters in the US region.

Moreover, the presence of key market players active in urinary catheter manufacturing such as Boston Scientific Corporation, Becton, Dickinson and Company, Teleflex Incorporated, Cook, among others in the region also expected to augment the urinary catheters market in the region.

Additionally, the Asia-pacific region has future potential for the urinary catheters market. The aging population in the region, along with constantly increasing urological disorders such as urinary tract infection, prostate cancer, and others are growing the demand for urinary catheters. For instance, as per the GLOBOCAN 2020 data, about 34,540 new cases of prostate cancer were reported in India and 106,139 new cases of prostate cancer in Japan, among other APAC nations. Furthermore, improving the healthcare system, rise in disposable income, rapid urbanization, and government initiative to increase access to safe and affordable surgery, especially in low and middle-income countries will boost the urinary catheters market in the region.

Urinary Catheters Market Key Players:

Some of the key market players operating in the Urinary Catheters market include B. Braun Melsungen AG, Hangzhou Formed Medical Devices Co., Ltd., Boston Scientific Corporation, Cook, ConvaTec Inc., Becton, Dickinson, and Company., Teleflex Incorporated, Urocare Products, Inc., BACTIGUARD AB, Hollister Incorporated, Cardinal Health, Rocamed., Amecath, Go Medical Industries Pty Ltd., CURE MEDICAL, LLC, QMD™, Amsino International, Inc., J and M Urinary Catheters LLC., CompactCath, Ribbel International Limited., and others.

Recent Developmental Activities in the Urinary Catheters Market:

In March 2021, Hollister Incorporated launched the Infyna Chic™ intermittent catheter, the latest in the company's line of hydrophilic catheter products to the US market.

In February 2021, Health Canada approved Bactiguard's urinary catheter with a temperature sensor for infection prevention driven by COVID-19. This is because Bactiguard’s catheter reduces the risk for secondary infection in critically ill patients.

In December 2020, Ingenion Medical Limited received nearly ?100,000 in grant funding from Innovate UK, the country’s innovation agency. The company planned to utilize the proceeds to gain a CE Mark for its CymActive™ urinary catheter, a novel medical device to treat male patients suffering from chronic urinary retention.

Key Takeaways from the Urinary Catheters Market Report Study

Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyse suitable indicators, our experts are closely watching the Urinary Catheters market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Urinary Catheters Market.

Various opportunities available for the other competitor in the Urinary Catheters Market space.

What are the top-performing segments in 2020? How these segments will perform in 2026.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Urinary Catheters market growth in the coming future?

Target Audience who can be benefited from the Urinary Catheters Market Report Study

Urinary Catheters providers

Research organizations and consulting companies

Urinary Catheters-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Urinary Catheters

Various End-users who want to know more about the Urinary Catheters Market and latest technological developments in the Urinary Catheters market.

Frequently Asked Questions for the Urinary Catheters Market:

1. What are Urinary Catheters?

Urinary catheters are flexible tubes used to empty the bladder and accumulate urine in a drainage bag. There are 3 main types of urinary catheter: intermittent, indwelling, and external. These catheters can be either inserted through the tube that carries urine out of the bladder (urethral catheter) or through a small opening made in your lower tummy (suprapubic catheter).

2. What is the market for Global Urinary Catheters?

The global Urinary Catheters market was valued at USD 3.10 billion in 2020, growing at a CAGR of 6.63% during the forecast period from 2021 to 2026, to reach USD 4.55 billion by 2026.

3. What are the drivers for the Global Urinary Catheters?

The major factors driving the demand for Urinary Catheters are the rising cases of urological disorders such as urine retention, urine incontinence, and bladder cancer among others coupled with the burgeoning geriatric population. In addition, recent product approval and product launches are also expected to propel the urinary catheters market.

4. What are the key players operating in Global Urinary Catheters?

Some of the key market players operating in the Urinary Catheters market include B. Braun Melsungen AG, Hangzhou Formed Medical Devices Co., Ltd., Boston Scientific Corporation, Cook, ConvaTec Inc., Becton, Dickinson, and Company., Teleflex Incorporated, Urocare Products, Inc., BACTIGUARD AB, Hollister Incorporated, Cardinal Health, Rocamed., Amecath, Go Medical Industries Pty Ltd., CURE MEDICAL, LLC, QMD™, Amsino International, Inc., J and M Urinary Catheters LLC., CompactCath, Ribbel International Limited., and others.

5. Which region has the highest share in the Urinary Catheters market?

Among all the regions, North America is expected to occupy a major share in the overall urinary catheters market during the forecasted period, 2021-2026. This domination is owing to the increasing occurrence of targeted indications, such as urinary retention, urinary incontinence, bladder obstruction, Benign Prostatic Hyperplasia & bladder cancers, among others. In addition, the presence of well-established healthcare facilities and reimbursement scenarios in the region will also contribute to the urinary catheters market
1. URINARY CATHETERS MARKET REPORT INTRODUCTION

2. URINARY CATHETERS MARKET EXECUTIVE SUMMARY

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. REGULATORY AND PATENT ANALYSIS

3.1. The United States
3.2. Europe
  3.2.1. Germany
  3.2.2. France
  3.2.3. Italy
  3.2.4. Spain
  3.2.5. The U.K.
3.3. Japan

4. URINARY CATHETERS MARKET KEY FACTORS ANALYSIS

4.1. Urinary Catheters Market Drivers
  4.1.1. Growing prevalence of urological disorders
  4.1.2. Increasing product launches across the globe
  4.1.3. Favourable reimbursement for the urinary catheters
  4.1.4. Technological advancement in the materials used for manufacturing the urinary catheters
4.2. Urinary Catheters Market Restraints and Challenges
  4.2.1. Complications such as catheter-associated urinary tract infection
  4.2.2. The stringent regulatory approval process of the urinary catheters
4.3. Urinary Catheters Market Opportunities
  4.3.1. Growth opportunities in low-income regions
  4.3.2. Growth opportunities bacteria phobic urinary catheter

5. URINARY CATHETERS PORTER’S FIVE FORCES ANALYSIS

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes 5.5 Competitive Rivalry

6. COVID-19 IMPACT ANALYSIS ON URINARY CATHETERS MARKET

7. URINARY CATHETERS MARKET LAYOUT

7.1. By Product Type
  7.1.1. Indwelling/Foley Catheters
  7.1.2. Intermittent catheters
  7.1.3. External Catheters
7.2. By Type
  7.2.1. Coated
  7.2.2. Uncoated
7.3. By Design
  7.3.1. Single Lumen
  7.3.2. Double Lumen
  7.3.3. Triple Lumen
7.4. By Usage
  7.4.1. Male Urinary Catheters
  7.4.2. Female Urinary Catheters
7.5. By Application
  7.5.1. Benign Prostatic Hyperplasia
  7.5.2. Urinary Incontinence
  7.5.3. General Surgery
  7.5.4. Others
7.6. By End-user
  7.6.1. Hospitals
  7.6.2. Ambulatory Surgical Centres
  7.6.3. Others
7.7. By Geography
  7.7.1. North America
    7.7.1.1. North America Urinary Catheters Market, by Product Type
    7.7.1.2. North America Urinary Catheters Market, by Type
    7.7.1.3. North America Urinary Catheters Market, by Design
    7.7.1.4. North America Urinary Catheters Market, by Usage
    7.7.1.5. North America Urinary Catheters Market, by Application
    7.7.1.6. North America Urinary Catheters Market, by End User
    7.7.1.7. North America Urinary Catheters Market, by Country
      7.7.1.7.1. United States
      7.7.1.7.2. Canada
      7.7.1.7.3. Mexico
  7.7.2. Europe
    7.7.2.1. Europe Urinary Catheters Market, by Product Type
    7.7.2.2. Europe Urinary Catheters Market, by Type
    7.7.2.3. Europe Urinary Catheters Market, by Design
    7.7.2.4. Europe Urinary Catheters Market, by Usage
    7.7.2.5. Europe Urinary Catheters Market, by Application
    7.7.2.6. Europe Urinary Catheters Market, by End User
    7.7.2.7. Europe Urinary Catheters Market, by Country
      7.7.2.7.1. France
      7.7.2.7.2. Germany
      7.7.2.7.3. United Kingdom
      7.7.2.7.4. Italy
      7.7.2.7.5. Spain
      7.7.2.7.6. Russia
      7.7.2.7.7. Rest of Europe
  7.7.3. Asia-Pacific
    7.7.3.1. Asia-Pacific Urinary Catheters Market, by Product Type
    7.7.3.2. Asia-Pacific Urinary Catheters Market, by Type
    7.7.3.3. Asia-Pacific Urinary Catheters Market, by Design
    7.7.3.4. Asia-Pacific Urinary Catheters Market, by Usage
    7.7.3.5. Asia-Pacific Urinary Catheters Market, by Application
    7.7.3.6. Asia-Pacific Urinary Catheters Market, by End User
    7.7.3.7. Asia-Pacific Urinary Catheters Market, by Country
      7.7.3.7.1. China
      7.7.3.7.2. Japan
      7.7.3.7.3. India
      7.7.3.7.4. Australia
      7.7.3.7.5. South Korea
      7.7.3.7.6. Rest of Asia Pacific
  7.7.4. Rest of the World (RoW)
    7.7.4.1. RoW Urinary Catheters Market, by Product Type
    7.7.4.2. RoW Urinary Catheters Market, by Type
    7.7.4.3. RoW Urinary Catheters Market, by Design
    7.7.4.4. RoW Urinary Catheters Market, by Usage
    7.7.4.5. RoW Urinary Catheters Market, by Application
    7.7.4.6. RoW Urinary Catheters Market, by End User
    7.7.4.7. RoW Urinary Catheters Market, by Region
      7.7.4.7.1. Middle East
      7.7.4.7.2. Africa
      7.7.4.7.3. South America

8. URINARY CATHETERS GLOBAL COMPANY SHARE ANALYSIS – KEY 3-5 COMPANIES

9. URINARY CATHETERS COMPANY AND PRODUCT PROFILES

9.1. B. Braun Melsungen AG
  9.1.1. Company Overview
  9.1.2. Company Snapshot
  9.1.3. Financial Overview
  9.1.4. Product Listing
  9.1.5. Entropy
9.2. Hangzhou Formed Medical Devices Co., Ltd.
  9.2.1. Company Overview
  9.2.2. Company Snapshot
  9.2.3. Financial Overview
  9.2.4. Product Listing
  9.2.5. Entropy
9.3. Boston Scientific Corporation
  9.3.1. Company Overview
  9.3.2. Company Snapshot
  9.3.3. Financial Overview
  9.3.4. Product Listing
  9.3.5. Entropy
9.4. Cook
  9.4.1. Company Overview
  9.4.2. Company Snapshot
  9.4.3. Financial Overview
  9.4.4. Product Listing
  9.4.5. Entropy
9.5. ConvaTec Inc.
  9.5.1. Company Overview
  9.5.2. Company Snapshot
  9.5.3. Financial Overview
  9.5.4. Product Listing
  9.5.5. Entropy
9.6. Becton, Dickinson and Company
  9.6.1. Company Overview
  9.6.2. Company Snapshot
  9.6.3. Financial Overview
  9.6.4. Product Listing
  9.6.5. Entropy
9.7. Teleflex Incorporated
  9.7.1. Company Overview
  9.7.2. Company Snapshot
  9.7.3. Financial Overview
  9.7.4. Product Listing
  9.7.5. Entropy
9.8. Urocare Products, Inc.
  9.8.1. Company Overview
  9.8.2. Company Snapshot
  9.8.3. Financial Overview
  9.8.4. Product Listing
  9.8.5. Entropy
9.9. BACTIGUARD AB
  9.9.1. Company Overview
  9.9.2. Company Snapshot
  9.9.3. Financial Overview
  9.9.4. Product Listing
  9.9.5. Entropy
9.10. Hollister Incorporated
  9.10.1. Company Overview
  9.10.2. Company Snapshot
  9.10.3. Financial Overview
  9.10.4. Product Listing
  9.10.5. Entropy
9.11. Cardinal Health
  9.11.1. Company Overview
  9.11.2. Company Snapshot
  9.11.3. Financial Overview
  9.11.4. Product Listing
  9.11.5. Entropy
9.12. Rocamed.
  9.12.1. Company Overview
  9.12.2. Company Snapshot
  9.12.3. Financial Overview
  9.12.4. Product Listing
  9.12.5. Entropy
9.13. Amecath
  9.13.1. Company Overview
  9.13.2. Company Snapshot
  9.13.3. Financial Overview
  9.13.4. Product Listing
  9.13.5. Entropy
9.14. Go Medical Industries Pty Ltd.
  9.14.1. Company Overview
  9.14.2. Company Snapshot
  9.14.3. Financial Overview
  9.14.4. Product Listing
  9.14.5. Entropy
9.15. CURE MEDICAL, LLC
  9.15.1. Company Overview
  9.15.2. Company Snapshot
  9.15.3. Financial Overview
  9.15.4. Product Listing
  9.15.5. Entropy
9.16. QMD™
  9.16.1. Company Overview
  9.16.2. Company Snapshot
  9.16.3. Financial Overview
  9.16.4. Product Listing
  9.16.5. Entropy
9.17. Amsino International, Inc.
  9.17.1. Company Overview
  9.17.2. Company Snapshot
  9.17.3. Financial Overview
  9.17.4. Product Listing
  9.17.5. Entropy
9.18. J and M Urinary Catheters LLC.
  9.18.1. Company Overview
  9.18.2. Company Snapshot
  9.18.3. Financial Overview
  9.18.4. Product Listing
  9.18.5. Entropy
9.19. CompactCath
  9.19.1. Company Overview
  9.19.2. Company Snapshot
  9.19.3. Financial Overview
  9.19.4. Product Listing
  9.19.5. Entropy
9.20. Ribbel International Limited.
  9.20.1. Company Overview
  9.20.2. Company Snapshot
  9.20.3. Financial Overview
  9.20.4. Product Listing
  9.20.5. Entropy

10. PROJECT APPROACH

10.1. Secondary Sources
10.2. Primary Sources
10.3. Data Triangulation
10.4. Key Expert Opinions

11. KOL VIEWS

12. DELVEINSIGHT CAPABILITIES

13. DISCLAIMER

14. ABOUT DELVEINSIGHT



More Publications